| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Lerapolturev | Phase 2 Clinical | Duke University Medical Center, Istari Oncology Inc, National Cancer Institute | Astrocytoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Embryonal; Ependymoma; Glioblastoma; Glioma; Gliosarcoma; Medulloblastoma; Melanoma; Oligodendroglioma; Solid tumours; Urinary Bladder Neoplasms | Details | |
| NTX-1088 | Phase 1 Clinical | Nectin Therapeutics Ltd | Neoplasm Metastasis; Neoplasms; Solid tumours | Details |
